Macrocyclic compounds as inhibitors of viral replication
US7491794B2 · kind B2 · utility
109Cited by
44References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2005 |
| Grant date | Feb 17, 2009 |
| Priority date | — |
| Expiry date | May 2, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.